The Ministry of Health has officially issued Decision No. 165/QĐ-BYT regarding the withdrawal of the Certificate of Eligibility for Pharmacy Business for Vimedimex Medi-Pharma Joint Stock Company. This move signals a strategic shift in the company’s operational structure within the pharmaceutical market.
Key legal details:
-
Subject: Certificate No. 632/ĐKKDD-BYT (issued on September 15, 2021).
-
Previous business scope: Engaging in the export, import, and provision of drug storage services.
-
Relevant locations: Headquarters in Hoan Kiem District and business premises in Nam Tu Liem District, Hanoi.
Rationale and implications:
The revocation was executed following a voluntary request from the company. According to the official correspondence sent to the Ministry of Health, Vimedimex stated that due to changes in business strategy and requirements, the previously licensed scope of operations is no longer aligned with its current development goals.
Effective immediately with this new decision, all prior pharmaceutical business licenses granted to Vimedimex are officially void. This implies that the company will cease or transition its drug import, export, and warehousing functions as defined under the previous certification.